Ergot mesylates for alzheimer's disease: A year-long double-blind trial of 3 mg vs 12 mg daily

This publication has 21 references indexed in Scilit:

• A Controlled Double‐Blind Study of High‐Dose Dihydroergotoxine Mesylate (Hydergine^R) in Mild Dementia
  Journal of the American Geriatrics Society, 1987
• Differential Patterns of Memory Loss Among Patients With Alzheimer's Disease, Huntington's Disease, and Alcoholic Korsakoff's Syndrome
  Archives of Neurology, 1986
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984
• Contextual cues and release from proactive inhibition in young and old people.
  Canadian Journal of Psychology / Revue canadienne de psychologie, 1983
• A Controlled Long‐term Study with Ergoloid Mesylates (Hydergine®) in Healthy, Elderly Volunteers: Results after Three Years
  Journal of the American Geriatrics Society, 1983
• An overview of pharmacologic treatment of cognitive decline in the aged
  American Journal of Psychiatry, 1981
• Cerebral Blood Flow in Dementia
  Archives of Neurology, 1975
• Mental Decline in the Elderly: Pharmacotherapy (Ergot Alkaloids versus Papaverine)
  Journal of the American Geriatrics Society, 1975
• Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency
  Current Medical Research and Opinion, 1973
• An Ergot Preparation (Hydergine) for Relief of Symptoms of Cerebrovascular Insufficiency
  Journal of the American Geriatrics Society, 1972